The effect of vasoactive agents on post-pressure hyperemia

Copyright © 2012 Elsevier Inc. All rights reserved..

The cutaneous hyperemic response following the release of direct pressure occlusion lasts much longer than the short-term hyperemia that occurs after proximal arterial occlusion. Post-pressure hyperemia may be an important mechanism to prevent pressure induced injury to the skin. The role of vasoactive mediators in modulating post-pressure hyperemia is unknown. In an effort to better understand this phenomenon, we performed an initial study using microdialysis infusion to measure the effect of several known mediators of vascular response on post-pressure hyperemia. A vise clamp was used to apply direct occlusive pressure to a laser Doppler sensor on the skin surface overlying the microdialysis fiber. Skin blood flow was measured continuously pre, during and post-occlusion while infusing the vasoactive substance or control phosphate buffer. Angiotensin II, Calcitonin gene related peptide and histamine had minimal effect on post pressure blood flow. Conversely, prostaglandin E1, prostaglandin E2, and L-NAME diminished the early phase of the post-occlusion hyperemic response. Perhaps the most profound effect we observed was the decrease in post-occlusive blood flow due to administration of epinephrine, dopamine and prostaglandin F2alpha. In contrast, adenosine and caffeine augmented blood flow post occlusion. In this initial survey study, we have demonstrated differential effects of various vascular mediators on the post-pressure hyperemic phenomenon. Our findings may lead to the development of agents to prevent pressure sores by augmenting the skin blood flow response to locally applied pressure.

Medienart:

E-Artikel

Erscheinungsjahr:

2012

Erschienen:

2012

Enthalten in:

Zur Gesamtaufnahme - volume:84

Enthalten in:

Microvascular research - 84(2012), 3 vom: 26. Nov., Seite 345-50

Sprache:

Englisch

Beteiligte Personen:

Belzowzki, Anne [VerfasserIn]
Bergren, Dale [VerfasserIn]
Brugler, Alexandra [VerfasserIn]
Hillman, Brandon G [VerfasserIn]
Hillman, Kyle C [VerfasserIn]
Hillman, Shane R [VerfasserIn]
Kuss, Brandon [VerfasserIn]
Ngo, Binh T [VerfasserIn]
Pisarri, Thomas [VerfasserIn]
Rendell, Marc S [VerfasserIn]
Thompson, Shaun L [VerfasserIn]
Turner, Scott A [VerfasserIn]

Links:

Volltext

Themen:

3G6A5W338E
Adenosine
Alprostadil
Buffers
Caffeine
Dinoprostone
Dopamine
Epinephrine
F5TD010360
Journal Article
K72T3FS567
K7Q1JQR04M
NG-Nitroarginine Methyl Ester
Phosphates
V55S2QJN2X
VTD58H1Z2X
Vasoconstrictor Agents
YKH834O4BH

Anmerkungen:

Date Completed 26.04.2013

Date Revised 21.11.2013

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.mvr.2012.07.001

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM219752842